Jiangsu Nhwa Pharmaceutical Co., LTD

SZSE:002262.SZ

24.05 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20242023202220212020201920182017201620152014201320122011201020092008200720062005
Operating Activities:
Net Income 1,140.7921,034.247880.389798.021727.104657.074519.162375.252301.686255.281221.254172.486138.13105.28375.11253.539.82226.31714.93114.989
Depreciation & Amortization 182.01164.085148.656135.06496.83388.151109.66560.64751.27649.5843.73136.69531.97927.65222.40520.26419.51116.53314.3488.594
Deferred Income Tax 0-23.204-4.0180.534-10.402-8.282-1.601-3.841-3.878-4.780000000000
Stock Based Compensation 0002.49510.89632.21225.2660000000000000
Change In Working Capital -501.483-201.748-160.563-251.118408.28-472.632-268.661-16.372-100.227-134.247-139.37-44.509-33.186-66.868-45.47-26.519-31.093-8.996-7.445-30.903
Accounts Receivables -512.981-199.064-155.276-122.875475.04-559.747-248.31266.588-166.876-71.039-124.921-70.361-118.4960000000
Inventory -71.79754.433-128.194-205.881-109.408-33.09-78.05-82.198-35.877-62.566-25.965-38.67-2.145-18.461-20.325-23.393-11.841-6.226-10.55-16.391
Accounts Payables 0-33.912126.92577.10353.05128.48759.3023.079106.4054.1380000000000
Other Working Capital 83.295-23.204-4.0180.534-10.402-8.282-190.61165.826-64.35-71.68-113.405-5.839-31.041-48.408-25.145-3.126-19.252-2.773.105-14.512
Other Non Cash Items 94.80777.166-7.45816.12115.6389.4544.35932.82224.40733.62134.62229.6617.24115.019.74514.02718.26114.6979.15616.161
Operating Cash Flow 916.1271,050.546861.023701.1181,248.349305.973404.525452.349277.141204.235160.237194.332154.16481.07661.79261.27246.50148.55130.9898.841
Investing Activities:
Investments In Property Plant And Equipment -450.056-373.989-327.751-206.107-268.609-160.3-170.695-166.007-102.221-216.631-261.602-103.628-78.006-46.207-85.568-42.15-37.401-41.961-36.094-31.994
Acquisitions Net 0.459-0.130.0910.1545.779-6.185-6.63524.1221.3780.1880000000036.3734.702
Purchases Of Investments 00-5,527.50.344-0.8980.29-170-216-42.11800-14000000-2.315-0.09
Sales Maturities Of Investments 46.11942.24632.35834.48828.6426.0661.05024.501400000.2001.7060.06
Other Investing Activites -1,008-3.7635,133.9-221.4-676.864345.25-166.564-129.866-1200.1880.3690.1950.082-0.0130.441-9.8470.5340.099-36.094-31.994
Investing Cash Flow -1,411.478-335.637-688.902-392.522-911.95185.121-343.895-295.872-238.461-216.443-247.233-117.433-77.923-46.219-85.127-51.797-36.867-41.862-36.428-29.315
Financing Activities:
Debt Repayment -4025-80025.5285.16-30.82925-13493-8.3542723.843.2-57.710.538.38.2
Common Stock Issued 0000201.570000.58500000000000
Common Stock Repurchased 000-0.46-201.57-4.753-2.1580000000000000
Dividends Paid -323.775-201.518-201.518-100.759-101.913-77.129-63.974-46.418-40.747-40.65-37.466-35.724-25.562-22.419-16.586-21.954-14.238-11.438-29.52-8.279
Other Financing Activities 62.804-33.656-31.261-26.215-203.159095.55200536.581-00-0-00.441.59151.5393-023.293
Financing Cash Flow -300.971-210.174-240.779-127.434-305.071-56.362116.737-77.247-15.162361.93155.534-44.02428.4384.5817.65422.83679.6012.0628.7823.214
Other Information:
Effect Of Forex Changes On Cash 0.1710.4150.908-1.145-0.38-0.101-0.2980.080.1750.064-0.052-0.2350.191-0.330.202-0.096-0.28-0.045-0.00920.474
Net Change In Cash -796.151505.15-67.75180.01730.947434.63177.0779.3123.694349.787-31.51432.639104.8739.107-15.47932.40588.9548.7063.33223.214
Cash At End Of Period 1,213.4622,009.6131,504.4631,572.2121,392.1951,361.248926.618749.548670.239646.545296.758328.272295.633190.763151.656167.135134.738.7063.33223.214